United States v. KENDALL COMPANY
District Court, D. Massachusetts
1Opinion of the Court
MEMORANDUM AND ORDERS ON DEFENDANTS’ MOTIONS
GARRITY, District Judge.
This is a criminal prosecution on the basis of an information charging the defendant company and the manager of its pharmaceutical division with seven counts of unlawfully causing to be introduced and delivering for introduction into interstate commerce the drug digoxin which was adulterated within the meaning of 21 U.S.C. § 351(a) (2) (B) and 21 U.S.C. § 351(b). There are presently three defense motions pending in this case. The court received affidavits and memoranda of law and heard oral argument.
Motion to Dismiss
The first…
2Cases cited8 opinions
- Camara v. Municipal Court of City and County of San FranciscoSupreme Court of the United States · 1967
- See v. City of SeattleSupreme Court of the United States · 1967
- United States v. Thriftimart, Inc., a Corporation, Dba Smart & Final Iris Co., Gil P. Stewart, Wm. Todd, Sr., and Robert D. Jensen, IndividualsCourt of Appeals for the Ninth Circuit · 1970
- Triangle Candy Co. v. United StatesCourt of Appeals for the Ninth Circuit · 1944
- United States v. Bel-Mar Laboratories, Inc.District Court, E.D. New York · 1968
3 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Pueblo v. Andreu GonzálezSupreme Court of Puerto Rico · 1976
- National Ass'n of Pharmaceutical Manufacturers v. Department of Health & Human ServicesDistrict Court, S.D. New York · 1984
- United States v. Roux Laboratories, Inc.District Court, M.D. Florida · 1978